EFFECTIVENESS AND COSTS OF DIFFERENT STRATEGIES FOR THE DIAGNOSIS OF STABLE CORONARY ARTERY DISEASE- RESULTS FROM THE EVINCI STUDY

Author(s)

Turchetti G1, Lorenzoni V1, Bellelli S1, Pierotti F1, Rovai D2, Caselli C2, Underwood R3, Knuuti J4, Neglia D2
1Scuola Superiore Sant'Anna, Pisa, Italy, 2National Research Council, Pisa, Italy, 3Imperial College London, London, UK, 4University of Turku and Turku University Hospital, Turku, Finland

OBJECTIVES The analysis of different non-invasive imaging strategies in a European population of patients with stable angina could help the identification of the best approach for the diagnosis of significant CAD.  METHODS In 475 pts (291 males, 60±9 yrs) with stable angina enrolled in the EVINCI multicenter study, CT coronary angiography (CTCA) and stress imaging were performed before invasive coronary angiography (ICA). Significant CAD was defined as >50% stenosis in the left main or >70% stenosis in a major coronary vessel or 30-70% stenosis with fractional flow reserve ≤0.8. Nine non-invasive imaging strategies including CTCA or stress imaging (ECHO, CMR, SPECT or PET) alone or in combination with CTCA performed as first line examinations were evaluated. Combinations were positive if both CTCA and the stress test were positive and their performance was evaluated in terms of accuracy (AUC). Centres specific reimbursements were collected for invasive and non-invasive examination and the costs associated with different strategies were obtained at individual patient level by summing up reimbursement of the examinations involved. RESULTS Significant CAD was diagnosed at ICA in 140 patients (29%). CTCA had the highest diagnostic performance among strategies involving single imaging modalities [0.91(0.88-0.94)] and CTCA-PET among combinations [0.84(0.74-0.93)]. Costs vary significantly among the strategies involving single non invasive modalities with value ranging from 425 Euro for ECHO to 1245 Euro for PET as well as for those involving combinations of imaging modalities ranging from 508 Euro for CTCA-ECHO to 870 Euro for CTCA-SPECT. CONCLUSIONS The diagnostic workflow for CAD detection shows variable effectiveness and costs according to the use of different single or combined non invasive imaging modalities. Data collected in the EVINCI study offer the opportunity to evaluate several diagnostic workflow from a combined clinical and economic perspective using a cost-effectiveness analysis.

Conference/Value in Health Info

2014-11, ISPOR Europe 2014, Amsterdam, The Netherlands

Value in Health, Vol. 17, No. 7 (November 2014)

Code

PCV8

Topic

Epidemiology & Public Health

Topic Subcategory

Disease Classification & Coding

Disease

Cardiovascular Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×